Canopy Growth Cannabis Q2 FY2024: Cost Reduction Impact On EBITDA, Debt And Margins

Canopy Growth Corporation WEED CGC released its Q2 FY2024 financial results late Thursday.

Canopy Growth Q2 FY2024 Results

  • Net Revenue: Canopy Growth reported net revenue of $70 million, showcasing significant YoY growth.
  • Gross Profits and Margin: The company achieved a consolidated gross margin of 34% in Q2 FY2024, a substantial turnaround from (1%) in Q2 FY2023. Canadian cannabis gross margins also improved to 36%.
  • Cost Reduction: The company reported an additional cost reduction of $54 million in Q2 FY2024, bringing the total reduction to $226 million since the beginning of FY2023. Canopy Growth targets a cost reduction of $270 million to $300 million by the end of FY2024.
  • Debt Reduction: The company reduced overall debt by $364 million to $681 million in Q2 FY2024, resulting in a total debt reduction of approximately $1 billion since the start of FY2023.
  • Adjusted EBITDA: Adjusted EBITDA loss improved to $12 million in Q2 FY2024, compared to a loss of $56 million in Q2 FY2023.

Improved Margins Amidst EBITDA Challenges

Canopy Growth's Q2 FY2024 financial results are promising, with improved margins and reduced debt.

However, the company still operates at a loss, with an adjusted EBITDA loss of $12 million.

The focus on international expansion and product launches in the U.S. THC platform indicates a positive growth trajectory that may attract investor interest.

Photo by Marek Studzinski on Unsplash

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: CannabisEarningsNewsPenny StocksSmall CapMarketsTrading IdeasCanopy Growth Corporationearnings reports
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.